Cataract surgerys short note elaborative 5 mark
| Type | Details |
|---|---|
| Topical | Proxymetacaine 0.5%, tetracaine 1% drops, or lidocaine 2% gel; most widely used today |
| Intracameral | Preservative-free lidocaine 0.2-1% (often combined as Mydrane - tropicamide 0.02% + phenylephrine 0.31% + lidocaine 1%) |
| Sub-Tenon | Blunt cannula injection; provides akinesia and analgesia |
| Peribulbar / Retrobulbar | Injections around/behind the globe; less commonly used now |
| General anaesthesia | Reserved for children, uncooperative patients |
| Type | Feature |
|---|---|
| Monofocal | Fixed focus at one distance (usually distance); most commonly implanted |
| Multifocal / EDOF | Extended depth of focus; reduces spectacle dependence |
| Toric | Corrects pre-existing corneal astigmatism; must be aligned to correct axis |
| Accommodating | Attempt to mimic natural accommodation |
| Phakic IOL | Implanted without removing the natural lens (for refractive correction) |
| Complication | Notes |
|---|---|
| Posterior capsule rupture (PCR) | Most feared intraoperative complication; ~0.5-2% rate; may require anterior vitrectomy |
| Vitreous loss | Follows PCR; raises risk of endophthalmitis, CMO, retinal detachment |
| Zonular dehiscence | Especially in pseudoexfoliation, trauma, Marfan syndrome |
| Suprachoroidal haemorrhage | Rare (0.04% with phaco); expulsive if severe; stop surgery immediately and suture wound |
| Posterior dislocation of nucleus | Fragments fall into vitreous; requires pars plana vitrectomy |
| Complication | Notes |
|---|---|
| Endophthalmitis | ~0.03-0.05%; presents as severe pain, hypopyon, reduced vision; emergency - intravitreal antibiotics |
| Posterior Capsule Opacification (PCO) | Most common late complication ("after-cataract"); treated with Nd:YAG laser posterior capsulotomy |
| Corneal oedema | Endothelial cell loss; risk increased in Fuchs dystrophy |
| Cystoid Macular Oedema (CMO/Irvine-Gass syndrome) | Peaks at 4-6 weeks post-op; treated with topical NSAIDs/steroids |
| Retinal detachment | Risk ~0.5-1%; higher in myopes, vitreous loss cases |
| IOL dislocation | Into vitreous cavity; requires vitrectomy with repositioning or exchange |
| Refractive surprise | Biometry error; managed with spectacles, contact lenses, or IOL exchange |
95% of patients achieve visual acuity of 6/12 or better